. . . "10.1002/CLC.23451" . "Canakinumab to reduce deterioration of cardiac and respiratory function in SARS-CoV-2 associated myocardial injury with heightened inflammation (canakinumab in Covid-19 cardiac injury: The three C study)"@nl . . . . . . . . . "32830894" . . . "Venu Menon" . . . . . . . "Ossama K Abou Hassan" . "article scientifique publi\u00E9 en 2020"@fr . . . . . . . . . . . . . . . "Canakinumab to reduce deterioration of cardiac and respiratory function in SARS-CoV-2 associated myocardial injury with heightened inflammation (canakinumab in Covid-19 cardiac injury: The three C study)"@nl . . . . . "Robier Aguillon Prada" . . . . . . . "art\u00EDculu cient\u00EDficu espubliz\u00E1u n'agostu de 2020"@ast . . "b\u00E0i b\u00E1o khoa h\u1ECDc"@vi . . . . . . . . . . "Canakinumab to reduce deterioration of cardiac and respiratory function in SARS-CoV-2 associated myocardial injury with heightened inflammation (canakinumab in Covid-19 cardiac injury: The three C study)"@en . . . . . "2020-08-24T00:00:00Z"^^ . "Canakinumab to reduce deterioration of cardiac and respiratory function in SARS-CoV-2 associated myocardial injury with heightened inflammation (canakinumab in Covid-19 cardiac injury: The three C study)"@en . . . . . . . . . "Debasis Sahoo" . "scientific article published on 24 August 2020"@en . . "Danielle Brennan" . . . "wetenschappelijk artikel"@nl . "Siddharth Dugar" . "\u043D\u0430\u0443\u043A\u043E\u0432\u0430 \u0441\u0442\u0430\u0442\u0442\u044F, \u043E\u043F\u0443\u0431\u043B\u0456\u043A\u043E\u0432\u0430\u043D\u0430 24 \u0441\u0435\u0440\u043F\u043D\u044F 2020"@uk . . . . . . . . . . . . "Canakinumab to reduce deterioration of cardiac and respiratory function in SARS-CoV-2 associated myocardial injury with heightened inflammation (canakinumab in Covid-19 cardiac injury: The three C study)"@en . "Abhijit Duggal" . . . . . . . . . . . . . . . . . . . "Canakinumab to reduce deterioration of cardiac and respiratory function in SARS-CoV-2 associated myocardial injury with heightened inflammation (canakinumab in Covid-19 cardiac injury: The three C study)"@nl . . "Tom Kai Ming Wang" . . . . . . "Canakinumab to reduce deterioration of cardiac and respiratory function in SARS-CoV-2 associated myocardial injury with heightened inflammation (canakinumab in Covid-19 cardiac injury: The three C study)"@en . . . "Daniel A Culver" . . "Prabalini Rajendram" . . "Calvin C Sheng" . . . .